¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾÏÇÐȸ 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer (3ÀÏÂ÷) : 2023-11-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѾÏÇÐȸ 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer (3ÀÏÂ÷) : 2023-11-17
±³À°ÀÏÀÚ : 2023-11-17

±³À°Àå¼Ò : ¼­¿ï·Ôµ¥È£ÅÚ 2,3Ãþ

±³À°ÁÖÁ¦ : 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer (3ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486  

À̸ÞÀÏ : cancer2@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú, ¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ

Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 400,000¿ø  

ºñ°í "1. »çÀüµî·Ï: 1) ȸ¿ø 10¸¸¿ø, 2)ȸ¿ø(¾÷ü), ºñȸ¿ø 20¸¸¿ø, 3) ºñȸ¿ø(¾÷ü) 30¸¸¿ø, 4) Àü°øÀÇ/´ëÇпø»ý: 7¸¸¿ø

2. ÀϹݵî·Ï: 1) ȸ¿ø 20¸¸¿ø, 2)ȸ¿ø(¾÷ü), ºñȸ¿ø 30¸¸¿ø, 3) ºñȸ¿ø(¾÷ü) 40¸¸¿ø, 4) Àü°øÀÇ/´ëÇпø»ý: 10¸¸¿ø" 


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 08:30~09:00 AACR Cancer Progress Report 2023 Rajarshi Sengupta(American Association for Cancer Research)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 09:00~09:30 KCA Cancer Report 2023 ±èÅ¿ë(¼­¿ïÀÇ´ë)

ÈÞ½Ä 11¿ù 17ÀÏ 09:30~09:40 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 09:40~10:05 Measuring apoptotic priming with BH3 profiling: From laboratory tool to clinical diagnostic Anthony G. Letai(Dana-Farber Cancer Institute, Boston, MA)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 10:05~10:30 Update of K-MASTER: The first Korean Precision Oncology Initiative ¹Ú°æÈ­(°í·ÁÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 10:30~10:55 Patient-derived tumor organoid models for functional precision medicine Alice Soragni(University of California, Los Angeles, CA)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 10:55~11:20 A pragmatic precision medicine platform: KOSMOS trial ±è¼±¿µ(¼­¿ï¾Æ»êº´¿ø)

ÈÞ½Ä 11¿ù 17ÀÏ 11:20~11:40 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 11:40~12:20 The cancer dependency map and beyond William C. Hahn(Harvard Medical School, Boston, MA)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 12:30~13:10 Pembrolizumab unveiled: Illuminating its role in esophageal, GEJ and gastric cancer as a shining star in the dark ¾ÈÈ£Á¤(°¡Å縯ÀÇ´ë)

ÈÞ½Ä 11¿ù 17ÀÏ 13:10~13:40 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 13:40~14:05 Exploring the role of telomerase in senescence and exhaustion in CAR T cell immunotherapy Steven Artandi(Stanford Cancer Institute, Stanford, CA)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 14:05~14:30 Senescent tumor cell; The novel modulator of the cancer microenvironment ¹ÚÅÂÁØ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 14:30~14:55 Exploiting senescence to treat liver cancer M. Celeste Simon(Abramson Family Cancer Research Institute, Philadelphia, PA)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 14:55~15:20 The transcriptional hallmarks of oncogene-induced senescence: a combined meta-analysis and machine learning approach ±è¼º¿µ(°Ç±¹ÀÇ´ë)

ÈÞ½Ä 11¿ù 17ÀÏ 15:20~15:40 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 15:40~16:05 Highly multiplexed imaging for precision breast immuno-oncology Raza Ali(Cancer Research UK, London)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 16:05~16:30 Dissecting cellular heterogeneity and plasticity of lung cancer ±èÁ¾°æ(POSTECH)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 16:30~16:55 Understanding plasticity and histological transformation during emergence of resistance to targeted therapies Alvaro Quintanal-Villalonga(Memorial Sloan Kettering Cancer Center, New York, NY)

±³À°½Ã°£ 11¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ë 16:55~17:20 Anchorage plasticity reconstructs the metastatic cascade ¹ÚÇö¿ì(¿¬¼¼´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾÏÇÐȸ 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer (3ÀÏÂ÷) : 2023-11-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦43Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Ãß°èÇмú½ÉÆ÷Áö¾ö-ù°³¯ : 2023-11-17
´ÙÀ½±Û ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ Ãß°èÇмú´ëȸ(1ÀÏÂ÷) : 2023-11-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 35 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 34 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 30 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 26 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 30 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 43 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 24 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 22 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 21 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 19 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 25 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 27 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷